23rd Dec 2005 12:07
GlaxoSmithKline Cap KabushikiKaisha23 December 2005 GlaxoSmithKline Capital Kabushiki Kaisha GlaxoSmithKline Capital Kabushiki Kaisha ("GSK Capital KK") has reallocatedJPY17.3bn (GBP84m) in common stock to a reserve account to increasedistributable reserves. This is part of GlaxoSmithKline's continuing policy offacilitating the distribution of profits within the worldwide Group. GSK Capital KK is a wholly owned subsidiary of GlaxoSmithKline plc and acts as aJapanese resident financing company of the GlaxoSmithKline Group. The €500,000,000 3.25 per cent notes due 2009 issued by GSK Capital KK issuedunder the GlaxoSmithKline £5,000,000,000 Euro Medium Term Note Programme areguaranteed by GlaxoSmithKline plc, which has a long term debt rating of AA fromStandard and Poor's and Aa2 from Moody's Investors' Services. 23 December 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline